Search Login Register

Thiotepa (Triethylenethiophosphoramide) Summary

Description: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Also Known As: Triethylenethiophosphoramide; AI3-24916; Girostan; NSC-6396; Tespa Show All >>

Networked: 921 relevant articles (75 outcomes, 166 trials/studies) for this Drug

Key Diseases for which Thiotepa is Relevant

  1. Neoplasms (Cancer) : 20 outcomes 40 studies in 252 results
  2. Breast Neoplasms (Breast Cancer) : 12 outcomes 40 studies in 134 results
  3. Urinary Bladder Neoplasms (Bladder Cancer) : 8 outcomes 18 studies in 72 results
  4. Carcinoma (Carcinomatosis) : 5 outcomes 11 studies in 81 results
  5. Lymphoma (Lymphomas) : 3 outcomes 5 studies in 25 results
Show All >>

Drugs Related to Thiotepa

  1. Cyclophosphamide (Cytoxan)
  2. Carboplatin (JM8)
  3. Melphalan (Alkeran)
  4. Busulfan (Busulfex)
  5. Doxorubicin (Adriamycin)
  6. Etoposide (VP 16)
  7. Mitomycin (Mitomycin-C)
  8. Cisplatin (Platino)
  9. fludarabine
  10. Methotrexate (Mexate)
Show All >>

Therapies Related to Thiotepa

  1. Drug Therapy (Chemotherapy)
  2. Intravesical Administration
  3. Stem Cell Transplantation
  4. Transplantation (Transplant Recipients)
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.